Tumor characteristics and clinical outcome of elderly women with breast cancer - PubMed (original) (raw)
. 2000 Apr 5;92(7):550-6.
doi: 10.1093/jnci/92.7.550.
Affiliations
- PMID: 10749910
- DOI: 10.1093/jnci/92.7.550
Tumor characteristics and clinical outcome of elderly women with breast cancer
S G Diab et al. J Natl Cancer Inst. 2000.
Abstract
Background: The number of elderly patients with breast cancer is increasing. Limited age-related information available about this disease prompted this study.
Patients and methods: The study population was derived from 50828 and 256287 patients with invasive breast cancer in San Antonio breast cancer databases and the Surveillance, Epidemiology, and End Results (SEER) registry, respectively. Tumor biologic and clinical characteristics, local and systemic therapies, and survival according to the patient's age were analyzed. Survival was also compared with that of age-matched women from the general population.
Results: In patients 55 years old or older, there was an association between increasing age at diagnosis and the presence of more favorable biologic characteristics of the tumor, including more tumors that express steroid receptors, lower proliferative rates, diploidy, normal p53, and absence of the expression of epidermal growth factor receptor and c-erbB2. In older patients with lymph node-negative disease and/or small tumors, the observed and expected survivals were almost identical. In the SEER registry, the 8-year survival of lymph node-negative patients relative to the expected survival of age-matched women from the general population was 1.01 (95% confidence interval [CI] = 0.98-1. 04) for patients 70-74 years old, 1.06 (95% CI = 1.01-1.11) for patients 75-79 years old, and 1.09 (95% CI = 0.98-1.20) for patients 80-84 years old.
Conclusion: In women 55 years old or older, advancing age is associated with more favorable tumor biology, and breast cancer survival in older women is similar to survival in the general population irrespective of disease status. This favorable outcome should be considered when making clinical decisions in older patients.
Comment in
- Re: Tumor characteristics and clinical outcome of elderly women with breast cancer.
Basche M, Byers T. Basche M, et al. J Natl Cancer Inst. 2001 Jan 3;93(1):64-5; author reply 65-6. doi: 10.1093/jnci/93.1.64. J Natl Cancer Inst. 2001. PMID: 11136846 No abstract available. - Re: Tumor characteristics and clinical outcome of elderly women with breast cancer.
Weiss NS. Weiss NS. J Natl Cancer Inst. 2001 Jan 3;93(1):65; author reply 65-6. doi: 10.1093/jnci/93.1.65. J Natl Cancer Inst. 2001. PMID: 11136848 No abstract available. - Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
Mirchandani D, Muggia F. Mirchandani D, et al. J Natl Cancer Inst. 2001 Sep 19;93(18):1420-1; author reply 1421-2. doi: 10.1093/jnci/93.18.1420-a. J Natl Cancer Inst. 2001. PMID: 11562395 No abstract available.
Similar articles
- Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990 - Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.
Gago FE, Tello OM, Diblasi AM, Ciocca DR. Gago FE, et al. J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):431-7. doi: 10.1016/s0960-0760(98)00140-x. J Steroid Biochem Mol Biol. 1998. PMID: 10030692 - Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Gonzalez-Angulo AM, et al. Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review. - Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
Cao L, Sun PL, Yao M, Jia M, Gao H. Cao L, et al. Hum Pathol. 2017 Oct;68:166-174. doi: 10.1016/j.humpath.2017.08.032. Epub 2017 Sep 9. Hum Pathol. 2017. PMID: 28899737 Review.
Cited by
- Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.
Lu X, Li X, Ling H, Gong Y, Guo L, He M, Sun H, Hu X. Lu X, et al. Med Sci Monit. 2020 Sep 13;26:e925210. doi: 10.12659/MSM.925210. Med Sci Monit. 2020. PMID: 32920589 Free PMC article. - Specific Aspects of Breast Cancer Therapy of Elderly Women.
Tesarova P. Tesarova P. Biomed Res Int. 2016;2016:1381695. doi: 10.1155/2016/1381695. Epub 2016 Oct 11. Biomed Res Int. 2016. PMID: 27807536 Free PMC article. Review. - Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice.
Zhang C, Lei L, Yang X, Ma K, Zheng H, Su Y, Jiao A, Wang X, Liu H, Zou Y, Shi L, Zhou X, Sun C, Hou Y, Xiao Z, Zhang L, Zhang B. Zhang C, et al. J Immunother Cancer. 2021 Oct;9(10):e002809. doi: 10.1136/jitc-2021-002809. J Immunother Cancer. 2021. PMID: 34642245 Free PMC article. - Pharmacotherapeutic Management of Breast Cancer in Elderly Patients: The Promise of Novel Agents.
Terret C, Russo C. Terret C, et al. Drugs Aging. 2018 Feb;35(2):93-115. doi: 10.1007/s40266-018-0519-5. Drugs Aging. 2018. PMID: 29388072 Review. - The impact of age on outcome in early-stage breast cancer.
Beadle BM, Woodward WA, Buchholz TA. Beadle BM, et al. Semin Radiat Oncol. 2011 Jan;21(1):26-34. doi: 10.1016/j.semradonc.2010.09.001. Semin Radiat Oncol. 2011. PMID: 21134651 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous